Moore KA - Search Results

1

Gene transfer of adenosine deaminase into primitive human hematopoietic progenitor cells.

Cournoyer D, Scarpa M, Mitani K, Moore KA, Markowitz D, Bank A, Belmont JW, Caskey CT. Cournoyer D, et al. Among authors: moore ka. Hum Gene Ther. 1991 Fall;2(3):203-13. doi: 10.1089/hum.1991.2.3-203. Hum Gene Ther. 1991. PMID: 1751590

2

Use of cell-free retroviral vector preparations for transduction of cells from the marrow of chronic phase and blast crisis chronic myelogenous leukemia patients and from normal individuals.

Etkin M, Filaccio M, Ellerson D, Suh SP, Claxton D, Gaozza E, Brenner M, Moen R, Belmont J, Moore KA, et al. Etkin M, et al. Among authors: moore ka. Hum Gene Ther. 1992 Apr;3(2):137-45. doi: 10.1089/hum.1992.3.2-137. Hum Gene Ther. 1992. PMID: 1391033

3

Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells.

Moore KA, Deisseroth AB, Reading CL, Williams DE, Belmont JW. Moore KA, et al. Blood. 1992 Mar 15;79(6):1393-9. Blood. 1992. PMID: 1547339 Free article.

4

Leukemia inhibitory factor improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo.

Fletcher FA, Moore KA, Ashkenazi M, De Vries P, Overbeek PA, Williams DE, Belmont JW. Fletcher FA, et al. Among authors: moore ka. J Exp Med. 1991 Oct 1;174(4):837-45. doi: 10.1084/jem.174.4.837. J Exp Med. 1991. PMID: 1655947 Free PMC article.

5

Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector.

Moore KA, Scarpa M, Kooyer S, Utter A, Caskey CT, Belmont JW. Moore KA, et al. Hum Gene Ther. 1991 Winter;2(4):307-15. doi: 10.1089/hum.1991.2.4-307. Hum Gene Ther. 1991. PMID: 1838933

6

Effects of leukemia inhibitory factor (LIF) on gene transfer efficiency into murine hematolymphoid progenitors.

Fletcher FA, Moore KA, Williams DE, Anderson D, Maliszewski C, Belmont JW. Fletcher FA, et al. Among authors: moore ka. Adv Exp Med Biol. 1991;292:131-8. doi: 10.1007/978-1-4684-5943-2_15. Adv Exp Med Biol. 1991. PMID: 1950765

7

Gene therapy: a new approach for the treatment of genetic disorders.

Cournoyer D, Scarpa M, Jones SN, Moore KA, Belmont JW, Caskey CT. Cournoyer D, et al. Among authors: moore ka. Clin Pharmacol Ther. 1990 Jan;47(1):1-11. doi: 10.1038/clpt.1990.1. Clin Pharmacol Ther. 1990. PMID: 1967233 Review. No abstract available.

8

Characterization of recombinant helper retroviruses from Moloney-based vectors in ecotropic and amphotropic packaging cell lines.

Scarpa M, Cournoyer D, Muzny DM, Moore KA, Belmont JW, Caskey CT. Scarpa M, et al. Among authors: moore ka. Virology. 1991 Feb;180(2):849-52. doi: 10.1016/0042-6822(91)90105-k. Virology. 1991. PMID: 1989392

9

Human adenosine deaminase expression in mice.

Moore KA, Fletcher FA, Villalon DK, Utter AE, Belmont JW. Moore KA, et al. Blood. 1990 May 15;75(10):2085-92. Blood. 1990. PMID: 2337676 Free article.

10

Expression vectors for human adenosine deaminase gene therapy.

Moore KA, Fletcher FA, Alford RL, Villalon DK, Hawkins DH, MacGregor GR, Caskey CT, Belmont JW. Moore KA, et al. Genome. 1989;31(2):832-9. doi: 10.1139/g89-146. Genome. 1989. PMID: 2576653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters